Prospects of Marine Sterols against Pathobiology of Alzheimer’s Disease: Pharmacological Insights and Technological Advances

Md Ataur Rahman; Raju Dash; Abdullah Al Mamun Sohag; Mahboob Alam; Hyewhon Rhim; Hunjoo Ha; Il Soo Moon; Md Jamal Uddin; Md Abdul Hannan

doi:10.3390/MD19030167

Prospects of Marine Sterols against Pathobiology of Alzheimer’s Disease: Pharmacological Insights and Technological Advances

Md Ataur Rahman, Raju Dash, Abdullah Al Mamun Sohag, Mahboob Alam, Hyewhon Rhim, Hunjoo Ha, Il Soo Moon, Md Jamal Uddin, Md Abdul Hannan

Department of Pharmaceutical Sciences

Research output: Contribution to journal › Review article › peer-review

19 Scopus citations

Abstract

Alzheimer’s disease (AD) is a degenerative brain disorder characterized by a progressive decline in memory and cognition, mostly affecting the elderly. Numerous functional bioactives have been reported in marine organisms, and anti-Alzheimer’s agents derived from marine resources have gained attention as a promising approach to treat AD pathogenesis. Marine sterols have been investigated for several health benefits, including anti-cancer, anti-obesity, anti-diabetes, anti-aging, and anti-Alzheimer’s activities, owing to their anti-inflammatory and antioxidant properties. Marine sterols interact with various proteins and enzymes participating via diverse cellular systems such as apoptosis, the antioxidant defense system, immune response, and cholesterol homeostasis. Here, we briefly overview the potential of marine sterols against the pathology of AD and provide an insight into their pharmacological mechanisms. We also highlight technological advances that may lead to the potential application of marine sterols in the prevention and therapy of AD.

Original language	English
Article number	167
Journal	Marine Drugs
Volume	19
Issue number	3
DOIs	https://doi.org/10.3390/MD19030167
State	Published - Mar 2021

Bibliographical note

Funding Information:
I.S.M., M.A.H. and M.A.R. wish to acknowledge the National Research Foundation fellowship and grant (2018R1A2B6002232 to I.S.M., 2018H1D3A1A01074712 to M.A.H. and 2016H1D3A1908615 to M.A.R.) funded by the Ministry of Science, ICT and Future Planning. M.J.U. acknowledges National Research Foundation (No. 2020R1I1A1A01072879), and Brain Pool program funded by the Ministry of Science and ICT through the National Research Foundation (No. 2020H1D3A2A02110924), Korea.

Publisher Copyright:
© 2021 by the authors. Licensee MDPI, Basel, Switzerland.

Keywords

cholesterol homeostasis
fucosterol
inflammation
marine steroids
neurodegeneration
oxidative stress

Access to Document

10.3390/MD19030167

Cite this

@article{b76d0dedb7ea470bbdd60f0a2bcb0e3e,

title = "Prospects of Marine Sterols against Pathobiology of Alzheimer{\textquoteright}s Disease: Pharmacological Insights and Technological Advances",

abstract = "Alzheimer{\textquoteright}s disease (AD) is a degenerative brain disorder characterized by a progressive decline in memory and cognition, mostly affecting the elderly. Numerous functional bioactives have been reported in marine organisms, and anti-Alzheimer{\textquoteright}s agents derived from marine resources have gained attention as a promising approach to treat AD pathogenesis. Marine sterols have been investigated for several health benefits, including anti-cancer, anti-obesity, anti-diabetes, anti-aging, and anti-Alzheimer{\textquoteright}s activities, owing to their anti-inflammatory and antioxidant properties. Marine sterols interact with various proteins and enzymes participating via diverse cellular systems such as apoptosis, the antioxidant defense system, immune response, and cholesterol homeostasis. Here, we briefly overview the potential of marine sterols against the pathology of AD and provide an insight into their pharmacological mechanisms. We also highlight technological advances that may lead to the potential application of marine sterols in the prevention and therapy of AD.",

keywords = "cholesterol homeostasis, fucosterol, inflammation, marine steroids, neurodegeneration, oxidative stress",

author = "Rahman, {Md Ataur} and Raju Dash and Sohag, {Abdullah Al Mamun} and Mahboob Alam and Hyewhon Rhim and Hunjoo Ha and Moon, {Il Soo} and Uddin, {Md Jamal} and Hannan, {Md Abdul}",

note = "Funding Information: I.S.M., M.A.H. and M.A.R. wish to acknowledge the National Research Foundation fellowship and grant (2018R1A2B6002232 to I.S.M., 2018H1D3A1A01074712 to M.A.H. and 2016H1D3A1908615 to M.A.R.) funded by the Ministry of Science, ICT and Future Planning. M.J.U. acknowledges National Research Foundation (No. 2020R1I1A1A01072879), and Brain Pool program funded by the Ministry of Science and ICT through the National Research Foundation (No. 2020H1D3A2A02110924), Korea. Publisher Copyright: {\textcopyright} 2021 by the authors. Licensee MDPI, Basel, Switzerland.",

year = "2021",

month = mar,

doi = "10.3390/MD19030167",

language = "English",

volume = "19",

journal = "Marine Drugs",

issn = "1660-3397",

publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",

number = "3",

}

TY - JOUR

T1 - Prospects of Marine Sterols against Pathobiology of Alzheimer’s Disease

T2 - Pharmacological Insights and Technological Advances

AU - Rahman, Md Ataur

AU - Dash, Raju

AU - Sohag, Abdullah Al Mamun

AU - Alam, Mahboob

AU - Rhim, Hyewhon

AU - Ha, Hunjoo

AU - Moon, Il Soo

AU - Uddin, Md Jamal

AU - Hannan, Md Abdul

N1 - Funding Information: I.S.M., M.A.H. and M.A.R. wish to acknowledge the National Research Foundation fellowship and grant (2018R1A2B6002232 to I.S.M., 2018H1D3A1A01074712 to M.A.H. and 2016H1D3A1908615 to M.A.R.) funded by the Ministry of Science, ICT and Future Planning. M.J.U. acknowledges National Research Foundation (No. 2020R1I1A1A01072879), and Brain Pool program funded by the Ministry of Science and ICT through the National Research Foundation (No. 2020H1D3A2A02110924), Korea. Publisher Copyright: © 2021 by the authors. Licensee MDPI, Basel, Switzerland.

PY - 2021/3

Y1 - 2021/3

N2 - Alzheimer’s disease (AD) is a degenerative brain disorder characterized by a progressive decline in memory and cognition, mostly affecting the elderly. Numerous functional bioactives have been reported in marine organisms, and anti-Alzheimer’s agents derived from marine resources have gained attention as a promising approach to treat AD pathogenesis. Marine sterols have been investigated for several health benefits, including anti-cancer, anti-obesity, anti-diabetes, anti-aging, and anti-Alzheimer’s activities, owing to their anti-inflammatory and antioxidant properties. Marine sterols interact with various proteins and enzymes participating via diverse cellular systems such as apoptosis, the antioxidant defense system, immune response, and cholesterol homeostasis. Here, we briefly overview the potential of marine sterols against the pathology of AD and provide an insight into their pharmacological mechanisms. We also highlight technological advances that may lead to the potential application of marine sterols in the prevention and therapy of AD.

AB - Alzheimer’s disease (AD) is a degenerative brain disorder characterized by a progressive decline in memory and cognition, mostly affecting the elderly. Numerous functional bioactives have been reported in marine organisms, and anti-Alzheimer’s agents derived from marine resources have gained attention as a promising approach to treat AD pathogenesis. Marine sterols have been investigated for several health benefits, including anti-cancer, anti-obesity, anti-diabetes, anti-aging, and anti-Alzheimer’s activities, owing to their anti-inflammatory and antioxidant properties. Marine sterols interact with various proteins and enzymes participating via diverse cellular systems such as apoptosis, the antioxidant defense system, immune response, and cholesterol homeostasis. Here, we briefly overview the potential of marine sterols against the pathology of AD and provide an insight into their pharmacological mechanisms. We also highlight technological advances that may lead to the potential application of marine sterols in the prevention and therapy of AD.

KW - cholesterol homeostasis

KW - fucosterol

KW - inflammation

KW - marine steroids

KW - neurodegeneration

KW - oxidative stress

UR - http://www.scopus.com/inward/record.url?scp=85103919968&partnerID=8YFLogxK

U2 - 10.3390/MD19030167

DO - 10.3390/MD19030167

M3 - Review article

C2 - 33804766

AN - SCOPUS:85103919968

SN - 1660-3397

VL - 19

JO - Marine Drugs

JF - Marine Drugs

IS - 3

M1 - 167

ER -

Prospects of Marine Sterols against Pathobiology of Alzheimer’s Disease: Pharmacological Insights and Technological Advances

Abstract

Bibliographical note

Keywords

Access to Document

Fingerprint

Cite this